NANT 2011- 01: Randomized Phase II Pick the Winner Study of 131I-MIBG, 131I-MIBG With Vincristine and Irinotecan, or 131I-MIBG With Vorinostat for Resistant/Relapsed Neuroblastoma
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Iobenguane (Primary) ; Irinotecan; Vincristine; Vorinostat
- Indications Neuroblastoma
- Focus Therapeutic Use
- Acronyms NANT2011-01
- 11 Aug 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Oct 2017.
- 11 Aug 2017 Status changed from active, no longer recruiting to recruiting.
- 21 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Mar 2018.